179 results on '"Buhl, Roland"'
Search Results
2. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases
3. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
4. In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
5. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
6. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
7. German Asthma Net – Was haben wir bisher gelernt?
8. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
9. Characterization of Austrian severe asthma patients
10. Characterization of Obesity in Severe Asthma in the German Asthma Net
11. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
12. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
13. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
14. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
15. German asthma net: Nasal polyposis in patients in the severe asthma registry
16. Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study
17. Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness
18. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist
19. Disease-modifying anti-asthmatic drugs
20. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
21. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
22. Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion
23. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
24. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
25. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study
26. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.
27. Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning
28. Tezepelumab in patients with allergic and eosinophilic asthma.
29. Tezepelumab in patients with allergic and eosinophilic asthma
30. Pioneering a paradigm shift in asthma management: remission as a treatment goal
31. Pioneering a paradigm shift in asthma management: remission as a treatment goal.
32. Initiation, response assessment and switch of antibody therapies in patients with severe asthma – a survey among German specialists
33. Response to biologics and clinical remission in the adult GAN severe asthma cohort.
34. German Asthma Net: Nasal polyposis in patients with severe asthma
35. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry
36. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report
37. Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
38. Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study
39. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
40. The German Asthma Net: Anti-IL5(R) therapy reduces disease burden in a real-life severe asthma cohort in comparison to patients on maintenance OCS therapy
41. [Untitled]
42. Rhinitis associated with asthma is distinct from rhinitis alone: TARIA‐MeDALL hypothesis
43. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
44. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study
45. Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
46. Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States
47. Safety of combining biologics in severe asthma: Asthma‐related and unrelated combinations
48. Corrigendum to “Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma” [Pulm. Pharmacol. Therapeut. 70 (2021) 102068]
49. Corrigendum to “The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control” [Respir. Med. 195 (2022) 106793]
50. Nationale VersorgungsLeitlinie Asthma: Langfassung
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.